Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
Oncologist
; 28(3): 189-192, 2023 03 17.
Article
em En
| MEDLINE
| ID: mdl-36718020
ABSTRACT
Patients experience interindividual variation in response to analgesics, which may be partially explained by genetics. This commentary discusses a recently published trial on COMT genotype and opioid dose requirements and describes the potential role for COMT and other genes (eg, CYP2D6) on opioid therapy and the current evidence for germline pharmacogenetics and resources for opioid pharmacogenetics.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dor do Câncer
/
Neoplasias
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article